chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DIZZINESS/LIGHTHEADEDNESS; SORE ARM; FEELING TIRED; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient experienced passes out when treated with paracetamol. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN expiry: UNKNOWN) dose was not reported, administered on 28-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced feeling tired. On 28-APR-2021, the subject experienced dizziness/lightheadedness. On 28-APR-2021, the subject experienced sore arm. Laboratory data (dates unspecified) included: Skin test (NR: not provided) negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizziness/lightheadedness, and sore arm, and the outcome of feeling tired was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per the standard operating procedure as the case is assessed as non-serious.
symptoms began as blurry vision, extreme light sensitivity (couldn't open eyes because of pain), and severe headache.  He also had what looked like a red rash or blood bruise on both eyelids.  The symptoms got increasingly worse and his vision became completely blurry and he was unable to focus his eyes and his photosensitivity so severe that he had to be in a dark room, even when his eyes were closed.  His headache increased.  We initially went to an urgent care clinic where they ran bloodwork, and then we were sent to an eye specialist for a thorough exam, which was excruciating for him to sit through on account of having to examine his eyes open and with light.  After a few hours at the eye specialist we went home and he went to bed, unable to sleep because of his extreme headache.  The symptoms lasted the following day, and the day after with loss of visual focus, extreme headache, and the rash on his eyelids appeared to had gotten a bit worse.  I would say that Saturday evening his eyesight began getting gradually better (vaccine on Wednesday evening).  His headache and aversion to sound continued.  Over the next week his vision began gradually getting better, different eyes at different rates, as well as his headache.   He still has the rash on his eyelids.
12/04/2002:  Mother noticed child's right arm was red-child was scratching area.  Arm became swollen later in the day.  No fever.  Advised Tylenol, cold compresses today and warm compresses tomorrow.
No additional adverse event reported; Expired MMR II vaccine administered; This spontaneous report was received from a pharmacist referring to a 26-year-old male patient. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions or allergies were no reported.   On 17-FEB-2022, the patient was vaccinated with expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) recombinant human albumin (rHA) (Lot# S039316 and expiration date 04-DEC-2021) (exact dose and frequency were not reported) as prophylaxis. (expired product administered). There was no previous temperature excursion. No additional adverse event reported, no further information provided.
Took second dose of Vivotif on day 5; A spontaneous report was received from a physician assistant on 26SEP2022. It described a patient (unknown age and gender) who "took second dose of Vivotif on day 5" (PT: Inappropriate schedule of product administration). The patient took the Vivotif (typhoid vaccine live oral Ty21A) (lot number: unknown) for immunisation. It was reported that the patient took the first dose of Vivotif on 18SEP2022, and the second dose was taken on 22SEP2022. Reportedly the third and fourth dose of Vivotif was taken on 24SEP2022 and 26SEP2022 respectively. The outcome of the reported event was not applicable.  Action taken with Vivotif with respect to the reported event was not applicable.  No additional information was reported.  Company comment: It was reported that a patient took the second dose of Vivotif on day 5 (inappropriate schedule of product administration). Vivotif dose should be taken every other day, and the causality of inappropriate schedule of product administration is assessed as not applicable to Vivotif considering the nature of the event. The case is considered non serious as per medical assessment.; Sender's Comments: It was reported that a patient took the second dose of Vivotif on day 5 (inappropriate schedule of product administration). Vivotif dose should be taken every other day, and the causality of inappropriate schedule of product administration is assessed as not applicable to Vivotif considering the nature of the event. The case is considered non serious as per medical assessment.
pt recv vax 27MAR97 & w/in 24hr pt reported noted swelling, pain, erythema @ site of meningococcal vax;pt was treated w/4 doses of IV ATB & oral ATB;cellulitis spread from axilla region to elbow;cont pain & limited mobility;
On 5/4/98, the pt had a negative mumps titer. The pt sought unspecified medical treatment. The pt was re-vaccinated on 5/14/98. A titer was drawn on 5/11/99 indicated a negative mumps titer. A titer drawn on 5/19/99 indicated a negative mumps titer.
(+) redness, swelling, & bruising to (R) thigh by evening after vaccines were administered. Bruise by 1 PM 1-21. Redness Thurs. evening about 5 PM.
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 001B21A) for COVID-19 vaccination. Concurrent medical conditions included Idiopathic urticaria (Controlled - No changes) since 2019. Concomitant products included LISDEXAMFETAMINE MESILATE (VYVANSE) for ADD, OMALIZUMAB (XOLAIR) for Idiopathic urticaria, OMALIZUMAB for Urticaria. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced HEADACHE (Headache). The patient was treated with ACETAMINOPHEN for Headache, at a dose of 1 dosage form twice a day. On 07-Apr-2021, HEADACHE (Headache) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The patient reported symptoms started about 1-2 hours after second dosage of Covid 19 vaccine and lasted until evening, Patient took Acetaminophen twice during the headache according to label.  Patient was not concerned as he knew the reported side effects.  Patient did not experience any side effects with the first dosage. Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: On 21-May-2021, follow up document was received: Reporter requested to remove DOB of the patient. On 06-Jul-2021: Significant follow up information received contains events stop date. Medical history, concomitant medication and corrective treatment added. Patient details (Race and Ethnicity) added.
This case was reported by a consumer and described the occurrence of injection site redness in a 4-year-old female subject who was vaccinated with KINRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Previous and/or concurrent vaccination included MMR vaccine (non-gsk); manufacturer unspecified; unknown; right thigh given on 20 April 2010; unspecified vaccine; manufacturer unspecified; unknown; right thigh given on 20 April 2010. On 20 April 2010 the subject received unspecified dose of KINRIX (.5 ml, unknown, right thigh). On 20 April 2010, less than one day after vaccination with KINRIX, the subject experienced injection site redness, swelling injection site, injection site warmth, nodule injection site, injection site pain and maladministration. The injection site was warm, red with raise knot but not painful. At the time of the report, it remained red, but was no longer warm, swollen or painful. The subject also received an MMR vaccine and another vaccine in the same leg. At the time of reporting the injection site redness was unresolved.
discovered the vaccine  administed was from the day  before,  not the current   day vial
I had a pain in my left upper canine tooth last Monday. I went in on Wednesday and I had a periapical abscess of the tooth. Related to an old trauma that had damaged the tooth. I received a dental treatment that day, Pulpal Debridement, is what the treatment was. I had worse symptoms and swelling and went back on Friday and had an abscess that moved to side of cheek from the tooth and required an incision and drainage. I was put on antibiotics and I'm still on them. Flu shot: On September 14, 2021.
Sore throat Wednesday morning 12/28/2022 few hours later develop diarrhea; fever, chills developed Thursday body aches followed through Friday 12/30/2022 and decreased appetite. Fever broke Thursday night. Since then congestion; low appetite and soft stull.
1 of 6 pt's who was immunized from the same vial & devel a fever which lasted a couple of days & an inject site react which included redness & swelling; pt recovered;
The child had no reaction . The mother was called the day of the vaccine to be notified of error. She was called again on the third did not have any reaction .
Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Oct-2021, the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19) outcome was unknown.            Treatment included: Regeneron. No Concomitant medications were reported.; Sender's Comments: This report concerns a 91 year old female patient with no relevant medical history who experienced non-serious unexpected event of COVID-19 infection. The event occurred approximately 8 months after vaccination with second dose of mRNA-1273. The re-challenge is not applicable as the event happened after the second dose. The outcome of the event is unknown at the time of this report. The benefit-risk relationship of mRNA-1273 is not affected by this report. There is incomplete information about the second dose of the vaccine and the latency between the doses.
Red and warm and swollen; A little sore; Red and warm and swollen; Kind of firm; Red and warm and swollen; I just started some itching to my left arm around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Red and warm and swollen), VACCINATION SITE PRURITUS (I just started some itching to my left arm around the injection site), VACCINATION SITE INDURATION (Kind of firm), VACCINATION SITE ERYTHEMA (Red and warm and swollen) and VACCINATION SITE SWELLING (Red and warm and swollen) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (I just started some itching to my left arm around the injection site). On 12-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Red and warm and swollen), VACCINATION SITE INDURATION (Kind of firm), VACCINATION SITE ERYTHEMA (Red and warm and swollen) and VACCINATION SITE PAIN (A little sore). On an unknown date, the patient experienced VACCINATION SITE SWELLING (Red and warm and swollen). At the time of the report, VACCINATION SITE WARMTH (Red and warm and swollen), VACCINATION SITE PRURITUS (I just started some itching to my left arm around the injection site), VACCINATION SITE INDURATION (Kind of firm), VACCINATION SITE ERYTHEMA (Red and warm and swollen), VACCINATION SITE SWELLING (Red and warm and swollen) and VACCINATION SITE PAIN (A little sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided
Sort story, since getting the vaccine(s) I have experienced persistent body itch, GI-related abdominal pain, fatigue, and hypersensitivity to a variety of oral medications and to the endoscopy/biopsies, though tests have largely shown that I'm normal.  I got the second Pfizer-BioNTech Vaccine in my right arm on 04/23/2021, but the system won't let me enter that.  2 days after receiving the vaccines, I had fatigue and arm pain.  4 days after the vaccine, I was given one dose of flagil and a 5 day treatment of metronidazole for a suspected UTI or BV, even though tests for both came back negative.  I developed a severe body itch that has since died down but still intermittently persists 2.5 months after the first dose of the vaccine and 1.5 months after the second dose.  Topical steroids have done nothing to help, so they were discontinued.  4 days into the metronidazole I was told to discontinue due to significant adverse side effects.  About that time I also started having chest pain.  On or about April 14th I went to the ER for significant chest pain.  Tests were largely okay, and it was speculated that I had gastritis.  I was given an Rx for 20mg a day of omeprazole and told to get an endoscopy.  I discontinued the omeprazole due to significant adverse side effects.  I switched to 10mg of Pepcid for a couple of days, but I had significant side effects from that as well and discontinued therefore use.  I was feeling better (still with some intermittent fatigue and body itch) when I went in for the endoscopy on June 7.  I was told the procedure went really well and shouldn't anticipate much by way of side effects.  Later that afternoon, I started having a sore throat, abdominal cramps, and the next day I also started having some chest pain.  Called the doctor on call and received an Rx for dicyclomine, 2 pills x 2x day.  Did that for one day and started having blurry vision and mood alterations.  Discontinued that use and have slowly started feeling less cramps, but they still off-and-on persist.
This spontaneous case reported by a consumer, describes the occurrence of in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# unknown) for COVID-19 immunization. The patient's past medical history included kidney transplant on Mar 24, 2021. On Mar 18, 2021, patient received first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. Patient treated with Tylenol (paracetamol) ongoing since an unknown date, at an unspecified dose and frequency. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications reported.
In the post vaccine monitoring area he suddenly fall on the floor laying on his back.  He stated that he felt dizzy and light headed, he was placed on a stretcher vital signs BP-130/90, p- 104, o2sat 98%.  RRT team arrived and the ED team examined him, he denied hitting head Refused to go to the ED after being asked several times.  He stated that this happens to him all the time even after blood drawer Patient continued to be observed in the vaccine clinic vitals repeated he insisted on going home remained alert and oriented , discharged home at 16:45hrs accompanied by his partner.
swelling in the arm pit/swelling into the rib cage/described as lymphedema; Swollen lymph nodes; Headache; achy; This case was reported by a other health professional via call center representative and described the occurrence of lymphedema in a 51-year-old male patient who received Herpes zoster (Shingrix) (batch number M57C5, expiry date 9th April 2022) for prophylaxis.   On 23rd November 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 24th November 2019, 1 days after receiving Shingrix, the patient experienced lymphedema, lymphadenopathy cervical, headache and general body pain. The patient was treated with cephalexin (Keflex). On an unknown date, the outcome of the lymphedema, lymphadenopathy cervical, headache and general body pain were recovering/resolving.   It was unknown if the reporter considered the lymphedema, lymphadenopathy cervical, headache and general body pain to be related to Shingrix.  Additional case details were reported as follows: The patient received Shingrix and had swelling in the arm pit and into the rib cage described as lymphedema, along with swollen lymph nodes in the neck and a headache. The reporter consented to follow up.  At the time of reporting the events have improved. Provided by second line agent who MI was transferred The patient also felt achy. It progressed to a marble sized lump in the arm pit. The swelling continued down to rib cage. He went to his PCP and was prescribed Keflex.
Vaccination medication error (Comment: dose was given at another facility 14 days prior, did not notify staff of previous dose)
This spontaneous report as received from a licensed practical nurse (L.P.N.) refers to a female not pregnant patient in her 40's. On an unknown date, in the past, the patient was vaccinated with a dose of M-M-R II (dose, route, lot number not reported). On an unknown date in 2013, recently the patient had titer test that revealed positive for rubella but negative for measles. The patient's outcome was unknown. The patient sought medical attention, saw a nurse. The relationship between adverse event and M-M-R II was not reported. Additional information has been requested.
A spontaneous report has been received from a health professional. The report concerns a female patient (age 26 years, height 63 in, weight 120 lb). No medical history was reported. No concomitant products were reported. The patient received FLUMIST via nasal route, for flu prevention on an unknown date. During 2017, the patient experienced full body rash. Treatment with FLUMIST was not changed. The patient recovered from the event(s) on an unspecified date. The event was considered non-serious.
Symptoms started the evening of the injection. Extreme pain in extremities, muscle soreness, nausea, fatigue, migraine, back/neck pain, chills, fever. Mostly it feels as though my bones are in immense pain.
Two weeks after the vaccine I had a sudden and extreme elevation in blood pressure. My blood pressure is always been perfect. It has come down but it is Taken 2 or 3 months for it to come down.
Pt was given Pediatric dose of Hep B instead of Adult dose as her 3rd dose.
Tested NAAT positive for COVID 9/2/21 after being fully vaccinated.
pt recv vax 28FEB97 & pt became pregnant (LMP 27FEB97);pregnancy was confirmed w/blood test & sonogram;results of amniocentesis (chromosome & AFP) WNL;5DEC97 pt exp thrombosed hemorrhoids tx w/med;
Patient syncopize 3 hrs after vaccination. Pt also reported pain for 7-10 days in L upper chest and shoulder. Also reported being "cranky" and having headaches 6-8 weeks after.   Pt has history of SVT.
Pain in the back becoming so severe level 8.  Went to local doctors in hospital for four weeks trying to get help. Could not walk after the fourth week. Went to medical center and diagnosed within two hours of having acute osteomyelitis.  On the verge of sepsis.
foggy thinking, achy joints, fever and chills continuing starting at 4pm on date of vaccination and continuing until 2pm on Thursday the 29th
12/2/21: Vaccine given at 10:00am at employee vaccine clinic.  Notified by patient at 2:28pm that she was "breaking out with hives" and she had taken Benadryl. Patient contacted me again at 3:58pm that she was going to urgent care because the "hives are getting worse". At 6:48pm she reported "got the shot and medication for the next 5 days." 12/3/21 at 7:50am I contacted Patient to check on her status. She replied "still got 1 hive just took medication didn't go in hives on lips haven't cleared yet but it will....Dr said I will be ok....I good thankfully oh laying down drinking lots of water". 12/6/21 I went to her work site to check on her status and was told "she called out". I called her and left a voicemail to get more details for this report. On 12/7/21 I learned that Patient's daughter reported to the facility that Patient had died the night before. Her family provided no other details. We do not know the official cause of death or any more information at this point. We do not know which doctor or urgent care she visited on 12/2/21.
Body aches, feelings of hot cold,  dizziness, temp 101, chills,  mild joint pain,  resulting in loss of sleep. She drank fluids(some electrolytes), and took two Advil.
I was giving my second dose of the Pfizer at the drug store, the shot was administered and a little dribbled out so the pharmacist gave me a double dose.  I don't believe this was necessary and could have been avoided if the pharmacist would have followed better protocol administering the due to the poor quality of the administration of the shot I missed three days of work. My arm was unusable for 3 days.. I had some mucus buildup in my lungs.. but luckily after 5 days of good rest I'm okay.
It's more nausea and thrown out blood and cough, and coughing; Body ache; Just feeling unwell, Just feeling like sluggish; My legs are so hurting; Shortness of breath; Just feeling unwell, Just feeling like sluggish; Nausea; Coughing; This is a spontaneous report from a contactable consumer (patient herself). A 30-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via unknown route of administration on 23Aug2021 (lot number: FD8448) (age at vaccination 30-year-old) as dose 1, single for COVID-19 immunisation at pharmacy. The patient medical history included asthma, anxiety, heart problem and blood clot history from an unknown date and unknown if ongoing. The patient take tylenol for asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient had no prior vaccinations. The patient would like to report the side effects, as taken the COVID-19, the Pfizer first dose. The patient experienced as It's more nausea and thrown out blood and cough, and coughing, nausea, body ache, shortness of breath, just feeling unwell, just feeling like sluggish, legs are so hurting on 24Aug2021. I don't take the second one into the 13th of next month. The patient laboratory investigation included D-dimer test which revealed no clotting. The patient stated she had no body aches no more. She wanted to know, Why her legs were so hurting but it was not like persisting. It's more nausea and thrown out blood and cough, and coughing. The outcome of the event It's more nausea and thrown out blood and cough, and coughing, shortness of breath, just feeling unwell, just feeling like sluggish, nausea was unknown, legs are so hurting was recovering, body ache was recovered.  Follow-up attempts are completed. No further information is expected.